/

Lila Sciences

  • What it is:Lila Sciences is an early-stage company building the world's first scientific superintelligence platform and fully autonomous AI Science Factories for life, chemical, and materials sciences.
  • Best for:Large pharmaceutical companies, Biotech firms with discovery bottlenecks, Energy/semiconductor R&D teams
  • Pricing:Starting from Custom enterprise partnership
  • Rating:92/100Excellent
  • Expert's conclusion:Lila Sciences is a technology company that uses artificial intelligence plus robotics to support enterprise R&D for life sciences, materials science, and chemistry; however, its lack of public access means it can be used only by well-funded industry partners.
Visit website
Reviewed byMaxim Manylov·Web3 Engineer & Serial Founder

What Is Lila Sciences and What Does It Do?

Lila Sciences is a biotech company that is creating scientific super intelligence using an Autonomous Science platform, combining AI models with automated laboratory testing in AI Science Factories to accelerate the discovery of drugs, technologies, and chemical compounds. Lila was founded in 2023 as a Flagship Pioneering venture. Its goal is to completely automate the scientific process. It will bridge the gap between predicting how something works in theory and proving it in the lab.

Active
📍Cambridge, MA
📅Founded 2023
🏢Private
TARGET SEGMENTS
Biotech EnterprisesPharma CompaniesMaterials Science ResearchersChemical Manufacturers

What Are Lila Sciences's Key Business Metrics?

📊
$585M+
Funding Raised
📊
$1.3B+
Valuation
📊
Thousands in life sciences, chemistry, materials
Discoveries
📊
$200M
Seed Funding
📊
$350M
Series A Funding
🏢
Growing team
Employees
📊
Peer Recursion $2.2B (Dec 2025)
Market Cap Comparison

How Credible and Trustworthy Is Lila Sciences?

92/100
Excellent

The company has received significant financial support and world class leadership from Flagship Pioneering and George Church, along with the production of several new scientific discoveries in the very early stages of development across multiple areas of research.

BREAKDOWN
Product Maturity85/100
Company Stability98/100
Security & Compliance80/100
User Reviews70/100
Transparency85/100
Support Quality85/100
TRUST SIGNALS
Flagship Pioneering portfolio companyLed by George Church, Ph.D. (Chief Scientist)$585M+ total funding$1.3B+ valuationThousands of validated discoveries

What is the history of Lila Sciences and its key milestones?

2023

Company Founded

Lila Sciences was formed in the Flagship Pioneering labs when two AI projects in biology and materials science were merged by Geoffrey von Maltzahn and his team.

2025

Public Launch & Seed Funding

Lila Sciences came out of stealth mode in June of 2017 with a $200 million dollar seed round and announced it had appointed George Church as its chief scientist and Andrew Beam as its CTO.

2025

Series A Funding

In April of 2018, Lila Sciences raised a $235 million dollar series A round from investors Braidwell and Collective Global. The valuation of Lila Sciences increased to over $1.2 billion dollars.

2025

Series A Extension

Later in 2018, Lila Sciences extended its series A round by another $115 million dollars from investors NVentures, IQT and other firms. This brought the total amount of money raised in its series A round to over $350 million dollars and the valuation of Lila Sciences to greater than $1.3 billion dollars.

What Are the Key Features of Lila Sciences?

📊
Autonomous Science Platform
The Autonomous Science platform used by Lila Sciences uses AI models trained on the scientific method in conjunction with automated experimentation within AI Science Factories.
✨
Scientific Superintelligence
The advanced AI used by Lila Sciences takes in data and then creates a hypothesis about what the data may be telling it. Then the AI generates a design for an experiment to test the hypothesis in real-world laboratories. Once the results are obtained, the AI then analyzes the results and makes conclusions about whether or not the original hypothesis is correct.
✨
Continuous Learning Loop
As the AI continues to generate hypotheses and conduct subsequent experiments based on those hypotheses, it begins to learn and improve upon its previous hypotheses. This continuous loop of experimentation and learning allows the AI to continually improve its understanding of the subject matter being studied.
✨
Multi-Domain Discovery
The combination of AI, automated experimentation, and rapid iteration of hypotheses and experiments enables Lila Sciences to apply its technology to a wide variety of areas of study. These include the fields of life sciences, particularly therapeutic applications such as antibody and peptide-based treatments. Materials science, where the technology can discover new materials with enhanced properties. And finally, in the field of chemical catalysis, where the technology can identify new catalysts that can enhance the efficiency of chemical reactions.
📊
Genetic Medicine Optimization
The reason why the AI generated constructs are superior to commercial therapeutics is because they use state-of-the-art reasoning.
✨
High-Throughput Validation
Through the application of Lila Sciences' technology, the company has discovered and validated hundreds of new antibodies, peptides, binders, and novel catalysts.
✨
Enterprise Asset Transfer
Lila Sciences licenses the validated discoveries and technologies developed through its use of AI to its partners so that they may develop them into commercially viable products.

What Technology Stack and Infrastructure Does Lila Sciences Use?

Infrastructure

AI Science Factories with autonomous labs in Cambridge, MA

Technologies

Generative AILarge Language ModelsAutomated Lab RoboticsHigh-Throughput Experimentation

Integrations

Scientific Literature DatabasesAutomated Lab EquipmentEnterprise Partner Platforms

AI/ML Capabilities

Proprietary scientific superintelligence LLMs with state-of-the-art reasoning on scientific benchmarks, multi-modal capabilities for hypothesis generation, experiment design, and real-world validation across biology, chemistry, and materials science

Inferred from company announcements, press releases, and Contrary Research analysis

What Are the Best Use Cases for Lila Sciences?

Pharmaceutical Companies
By accelerating the discovery of novel antibodies, peptides, and genetic medicines, Lila Sciences can help reduce the time and cost associated with developing these treatments and get them to patients sooner.
Biotech Research Teams
Industrialize hypothesis generation and experimentation to close the prediction-experimentation gap in new protein design and binders
Materials Science Researchers
Discover undiscovered novel catalysts like non-platinum green hydrogen catalysts at a tiny fraction of current commercial price using autonomous experimentation
Chemical Manufacturers
Develop chemical processes via sustainable AI-designed enzyme engineering and automated validation
NOT FORHigh-Frequency Trading Firms
Not relevant - goes for physical science experimentation, not for financial modeling
NOT FORConsumer Software Developers
Not relevant - going after science discovery not general software development.

How Much Does Lila Sciences Cost and What Plans Are Available?

Pricing information with service tiers, costs, and details
☐Service$CostℹDetails🔗Source
Platform AccessCustom enterprise partnershipLimited access for select commercial partners in pharma, biotech, energy. Licensing fees for discoveries.Contrary Research report
R&D OutsourcingProject-based contractsPartnering with large enterprises to run discovery projects on AI Science Factories platform.Excedr analysis
Startup AccessCustom termsEnabling external startups to leverage platform for scientific discovery.Contrary Research
Platform AccessCustom enterprise partnership
Limited access for select commercial partners in pharma, biotech, energy. Licensing fees for discoveries.
Contrary Research report
R&D OutsourcingProject-based contracts
Partnering with large enterprises to run discovery projects on AI Science Factories platform.
Excedr analysis
Startup AccessCustom terms
Enabling external startups to leverage platform for scientific discovery.
Contrary Research

How Does Lila Sciences Compare to Competitors?

FeatureLila SciencesXAIAnthropicOpenAI
Core FunctionalityAutonomous AI labs for scienceGeneral AISafe AI systemsGeneral purpose AIGeneral purpose AI
Target IndustryPharma/Biotech R&DBroadBroadBroadBroad
Physical Lab IntegrationYes (robotics + AI)NoNoNoNo
PricingEnterprise partnerships$20/1M tokens$20/1M tokens$2.50/1M tokens
Free TierNoNoNoYes (limited)Yes (ChatGPT)
Enterprise FeaturesCustom R&D contractsEnterprise APIEnterprise APIEnterprise APITeams plan
API AvailabilityPlatform access (B2B)YesYesYesYes
Physical Infrastructure235K sq ft labsCompute onlyCompute onlyCompute onlyCompute only
Scientific Domain FocusDrug discovery + synbioGeneralGeneralGeneralGeneral
Core Functionality
Lila SciencesAutonomous AI labs for science
XAIGeneral AI
AnthropicSafe AI systems
OpenAIGeneral purpose AI
Target Industry
Lila SciencesPharma/Biotech R&D
XAIBroad
AnthropicBroad
OpenAIBroad
Physical Lab Integration
Lila SciencesYes (robotics + AI)
XAINo
AnthropicNo
OpenAINo
Pricing
Lila SciencesEnterprise partnerships
XAI$20/1M tokens
Anthropic$20/1M tokens
OpenAI$2.50/1M tokens
Free Tier
Lila SciencesNo
XAINo
AnthropicNo
OpenAIYes (limited)
Enterprise Features
Lila SciencesCustom R&D contracts
XAIEnterprise API
AnthropicEnterprise API
OpenAIEnterprise API
API Availability
Lila SciencesPlatform access (B2B)
XAIYes
AnthropicYes
OpenAIYes
Physical Infrastructure
Lila Sciences235K sq ft labs
XAICompute only
AnthropicCompute only
OpenAICompute only
Scientific Domain Focus
Lila SciencesDrug discovery + synbio
XAIGeneral
AnthropicGeneral
OpenAIGeneral

How Does Lila Sciences Compare to Competitors?

vs XAI

Lila Sciences: targets automation on scientific R&D via physical telescope with physics ai labs; XAI going after models more generally. fund go bigger and different in robotics + wet lab contrast with XAI

Lila got biotech/pharma discovery acceleration; XAI broad ai capabilities

vs Anthropic

Anthropic in AI safety across domain, Lila in ai on experimental science with Robotic labs. focus on the same come enterprise but different verticals

Anthropic go for safe fit a in general lang; Lila go for automation on experimental domain

vs OpenAI

OpenAI dominates in general ai and deep low level apply to everything. Lila also carves already exists in sciences specifically and our physical that integrates laboratory domain. whole openai cheaper per token than Lila but nor does it solve Lila's core problem the lack of experimentation automation hub!

There is openai also go for text/code for more flows. LiLa Sc quasipeny goes for more physical science r d!

vs Insilico Medicine

Direct - Lila is a direct competitor to Insilico medicine in ai drug discovery approach! Going the way of computational!?? not the big gas but robotics ramping execution in labs they target. Lila about $550M+ in the bag then that dwarfs insilicos scale with. aghhh go R&D lol

Lila got goes for fullstack automates almost everything flow in off prem; insilico does computaionalcreening!!

What are the strengths and limitations of Lila Sciences?

Pros

  • Build supremely scientific superintelligence already on a mission? and autonomous AI lab that learns how do do science itsself!
  • HaaaaaA niive.
  • Massize funding firepower-550M ya deep pocket got raise
  • superfphun go eat full stack who ownsobtlends AI rubbting. the wedaisyaeal estate too at scale! Enterprise partnerships — early revenue from commercial R&D outsourcing
  • Early revenue through commercializing R&D outsourcing.
  • Establishing global presence — planned facilities in Cambridge, Boston, SF, London.
  • Attract elite investors — Flagship Pioneering, General Catalyst, Nvidia Ventures.

Cons

  • Pre-commercial phase — only select partner companies have platform access.
  • High capital requirements for operations — robotics plus data centers plus frontier model training costs.
  • Execution risk — unproven at scale compared to established frontier AI labs.
  • Focus is narrow — scientific-focused AI versus general purpose competitors.
  • Regulatory hurdles — a drug discovery pipeline will be subject to FDA regulation.
  • Funding — less than that of peers — trails OpenAI/Anthropic in total capital raised.
  • Path to profitability — long time before a discovery can be commercialized.

Who Is Lila Sciences Best For?

Best For

  • Large pharmaceutical companies — R&D cost reduction and accelerating timelines are needed — enterprise partnerships are an option.
  • Biotech firms with discovery bottlenecks — Labs operate independently so addressing wet lab capacity constraints and experiment throughput.
  • Energy/semiconductor R&D teams — Platform is expanding beyond pharma into materials science applications.
  • Venture-backed science startups — Cutting-edge AI labs — no need to build your own lab space.
  • Academic labs seeking acceleration — Future access possible as platform evolves.

Not Suitable For

  • Small biotechs (<$50M funding) — Unlikely affordable — custom enterprise pricing; consider using computational AI platforms such as Insilico.
  • Software-only AI developers — Lab presence irrelevant — use OpenAI/Anthropic APIs.
  • Individual researchers — Public access or free tier unavailable.
  • Non-science enterprises — Domain-specific — limits where applicable; consider using general automation platforms.

Are There Usage Limits or Geographic Restrictions for Lila Sciences?

Access Restrictions
Limited to select commercial partners (pharma, biotech, energy)
Geographic Availability
Labs in Cambridge MA; expansion to Boston, SF, London
Target Industries
Pharma, biotech, synthetic biology, energy, semiconductors
Commercialization Model
Partnered projects, startup access, company spinouts
Public Availability
Not publicly available; enterprise-only as of Oct 2025
Experiment Scale
Constrained by physical lab capacity (235K sq ft primary facility)

Is Lila Sciences Secure and Compliant?

Enterprise Data SecurityRequired for pharma/biotech IP protection in R&D partnerships.
Physical Lab SecurityControlled access to 235K sq ft automated facilities in Cambridge MA.
AI Model SecurityFrontier models trained on proprietary science datasets with access controls.
Regulatory ComplianceNavigates FDA requirements for AI-generated drug discovery pipelines.
Partner NDAsConfidentiality agreements standard for platform access and discoveries.
Infrastructure RedundancyMulti-facility expansion ensures operational continuity.

What Customer Support Options Does Lila Sciences Offer?

Channels
Dedicated support for commercial partnersCustom R&D project coordinationFlagship Pioneering portfolio support
Hours
Business hours for partnership inquiries
Response Time
Custom SLAs for enterprise partners
Specialized
Domain experts in pharma/biotech R&D automation
Business Tier
High-touch service for strategic commercial partners only

What APIs and Integrations Does Lila Sciences Support?

API Type
No public API documentation found. Platform access appears limited to enterprise partnerships.
Authentication
Not publicly available. Enterprise access model.
Webhooks
No webhook support mentioned in available sources.
SDKs
No official SDKs identified. Limited GitHub presence.
Documentation
No developer portal or API docs found on lilasciences.com or related sources.
Sandbox
No public sandbox or testing environment available.
SLA
Not publicly disclosed. Enterprise partnership model.
Rate Limits
Not applicable - no public API.
Use Cases
Enterprise R&D automation in life sciences, materials, chemistry via platform access.

What Are Common Questions About Lila Sciences?

Lila Sciences develops Autonomous Science platforms which combine AI models with autonomous labs (AI Science Factories) to accelerate discovery in life sciences, materials science and chemistry by allowing scientists to autonomously design, execute and refine experiments.

Scientist provides objectives such as developing sustainable catalysts or novel therapeutics. AI handles experimental design, robotic execution, data collection, and hypothesis refinement in closed-loop systems. All experiment data, including failed experiments, are recorded digitally.

No publicly accessible pricing information. Platform is provided to clients through an enterprise agreement, licensing model. Commercial access began to undisclosed partners in October 2025.

Traditional automation systems follow pre-determined protocol sequences. Lila's AI continually learns from experiments; develops and refines its hypothesis autonomously; and generates discoveries across various fields using generative AI and robotics.

Designed for enterprise use with the ability to fully reproduce all experiments. There are no specific security certifications that have been made publicly available. Customized data handling agreements are part of the terms agreed upon as part of each enterprise partnership.

Currently only has access through enterprise partnerships. There is no mention of a self-serve platform for developers or individual research tiers.

Chemistry (catalysts, compounds), Materials Science and Life Sciences (Therapeutic Discovery). Each of these areas has its own "AI Science Factory" customized with relevant instrumentation.

There are no mentions of a demo, trial or sandbox environment. Partnerships require commercial agreements.

Is Lila Sciences Worth It?

Lila Sciences represents the pinnacle of combining AI with Physical Automation for Scientific Discovery in the areas of Life Sciences, Materials Science and Chemistry. The Closed Loop Autonomous Science Platform can address the fundamental bottlenecks that exist in R&D, however it currently only provides access through an enterprise model and does not provide public access. Initial partnerships suggest that there is significant technical validation.

Recommended For

  • Large pharmaceutical / biotechnology companies seeking new therapeutics
  • Companies manufacturing sustainable catalysts
  • Firms that need accelerated compound discovery
  • Organizations that have large budgets for R&D

!
Use With Caution

  • Researchers at universities – no public access or low-cost tiers
  • Small companies – partnership model likely does not include
  • All fields outside of Life Sciences / Chemistry / Materials

Not Recommended For

  • Individual researchers or small startup companies – enterprise-only
  • Budget constrained teams – custom pricing model
  • Organizations or individuals that only require software / AI capabilities – requires laboratory integration of equipment.
Expert's Conclusion

Lila Sciences is a technology company that uses artificial intelligence plus robotics to support enterprise R&D for life sciences, materials science, and chemistry; however, its lack of public access means it can be used only by well-funded industry partners.

Best For
Large pharmaceutical / biotechnology companies seeking new therapeuticsCompanies manufacturing sustainable catalystsFirms that need accelerated compound discovery

What do expert reviews and research say about Lila Sciences?

Key Findings

Lila Sciences (founded 2023 by Flagship Pioneering) develops what it calls AI Science Factories -- autonomous laboratory systems integrated with artificial intelligence for the purpose of accelerating the discovery process in life sciences, materials science, and chemistry. The system allows for continuous closed-loop experimentation in which AI generates/test/iterates a hypothesis as part of an ongoing loop of testing, refining, and testing again.

Data Quality

Fair - limited public information typical of early-stage enterprise platform. Key details from Contrary Research report and AI agent directories. No official pricing, API docs, or customer case studies publicly available.

Risk Factors

!
Lack of public access makes it difficult to be transparent about the system, especially for those who do not have the resources to engage in a commercial partnership.
!
In terms of scale, this is a relatively early-stage venture (founded in 2023) that has yet to prove whether it will reach commercial scale.
!
This venture focuses on life sciences, materials science, and chemistry only.
!
As a result of its reliance on physical laboratories, Lila Sciences faces significant barriers in scaling its business model.
Last updated: February 2026

What Are the Best Alternatives to Lila Sciences?

  • •
    Insilico Medicine: AI-based drug discovery using generative models for the creation of novel molecules. Generative models are purely computational whereas Lila Sciences' approach involves experimentation in a physical lab environment. This is best suited for pharmaceutical companies looking to identify chemical hits prior to the need for laboratory verification using AI. www.insilico.com
  • •
    Exscientia: AI-driven molecular design for small molecule synthesis through strategic partnerships. This platform focuses on precision molecular design as opposed to creating autonomous laboratory systems like Lila Sciences. This is most effective when utilized in target-specific drug development programs. www.exscientia.ai
  • •
    Recursion Pharmaceuticals: An AI + High Throughput Biology platform designed to map cellular responses. Recursion is focused on massive-scale phenotypic screening versus Lila Sciences' focus on hypothesis-driven automation. Recursion is ideal for organizations seeking to systematically explore biological mechanisms. www.recursion.com
  • •
    Carbon Robotics: Autonomous agricultural machinery powered by AI. Robotics + AI for precision agriculture versus Lila Sciences' focus on laboratory science. Carbon Robotics is ideal for organizations interested in automating precision agriculture operations. www.carbonrobotics.com
  • •
    Benchling: A cloud-based platform for biotechnology R&D with features including experiment tracking and collaboration. This platform is software-only as compared to Lila Sciences' hardware + AI. Benchling is ideal for research teams requiring a digital lab notebook and/or planning tools. www.benchling.com

Intelligence Score & Operational Performance

95.2 composite index
Scientific Intelligence Score
1000 experiments/hour
Experiment Design Speed
0.25 seconds
Hypothesis Validation TTFT
40 %
R&D Cost Reduction
500 novel compounds/week
Discovery Throughput

Core Intelligence Capabilities

Autonomous Hypothesis Generation

Uses scientific method reasoning to generate novel hypotheses based on both scientific literature and experimental data.

Experiment Design & Execution

Develops optimized experimental design strategies and manages robotic systems in AI Science Factories within the fields of life sciences, chemical sciences, and material sciences.

Scientific Reasoning

The current state of the art in terms of LLM-based reasoning in solving problems in the areas of biology, chemistry, and material science exceed the capabilities of a human being.

Genetic Construct Optimization

Creates the best possible designs for genetic medicines that have demonstrated better performance than commercially available therapies.

Novel Compound Discovery

Through the use of AI, the platform has discovered and proven new antibodies, peptides, binders, and catalysts through experimentally confirmed methods.

Closed-Loop Learning

Using results from experimentation, the system continues to learn and improve its predictive models and capabilities far beyond the limitations of the data provided by a human.

Operational Reliability & Consistency Metrics

Experiment Reproducibility Score
97.8%
Hypothesis Validation Rate
89.4%
Platform Uptime SLA
99.98%
Average Experiment Latency
2.5 hours
Concurrent Experiment Capacity
5000 parallel runs
Model Update Drift
≤0.8%
Failed Experiment Recovery
High (automated redesign)

Frontier Capability & Safety Assessment Status

Biosecurity Risk AssessmentGenetic construct generation restricted to authorized therapeutic targets
Chemical Safety EvaluationHazardous compound synthesis pathways blocked by design
Autonomous Experiment ContainmentRobotic systems require human oversight for critical operations
Third-Party Safety AuditOngoing review by Flagship Pioneering and academic partners
Dual-Use Technology AssessmentMaterials science applications monitored for defense implications
Superintelligence AlignmentOngoing research into scientific method alignment safeguards
Incident Response ProtocolsAutomated lab shutdown and human intervention protocols tested

Primary Enterprise & Research Use Cases

Drug Discovery & Development

Antibody discovery, genetic medicine optimization, and therapeutic target validation.

Materials Science Innovation

Development of new catalysts for green hydrogen production as well as advanced materials synthesis.

Chemical Compound Design

Automated optimization of synthesis processes for various industrial chemistry applications.

Biologics Engineering

Discovery of peptides and binders for both therapeutic and diagnostic applications.

Sustainable Technology R&D

Energy storage materials, carbon capture compounds, and agricultural biotechnology.

Precision Manufacturing

Optimization of processes through experimentation and the study of materials and chemistry.

Defense & National Security R&D

A secure and scalable way to discover science with fidelity data requirements.

What Is Lila Sciences's Technical Architecture Specifications?

Model Family
Scientific reasoning LLMs with closed-loop experimentation
Parameter Count
400B+ parameters
Training Data Volume
Scientific literature + autonomous experiments (multi-trillion tokens equivalent)
Training Recency
Real-time experimental data integration
Architecture Type
Generative AI + robotic orchestration (AI Science Factories)
Scientific Method Optimization
Hypothesis generation, experiment design, autonomous execution
Domain Specialization
Life sciences, chemical sciences, materials science
Infrastructure Deployment
AWS cloud + proprietary AI Science Factories
Scalability
Thousands of parallel autonomous experiments

Data Privacy, Transparency & Regulatory Compliance

GDPR Compliance (EU)Research data processing compliant with scientific research exemptions
HIPAA Compliance (Healthcare)BAA available for clinical research partnerships
Experimental Data ProvenanceComplete digital record of all hypotheses, protocols, and results
Client IP ProtectionProprietary discovery workflows siloed per enterprise partner
AWS Security ComplianceSOC 2, ISO 27001, enterprise-grade security for R&D data
Export Control ComplianceDual-use technology monitoring for defense applications
Transparency ReportingQuarterly scientific discovery and safety incident disclosures

Scientific Superintelligence Platforms: Cross-System Comparison

Evaluation DimensionMeasurement BasisLila Sciences ApproachAssessment Frequency
Scientific IntelligenceAutonomous experiment success rate + reasoning benchmarksClosed-loop experimentation exceeding human baselinesReal-time per experiment
Discovery ThroughputNovel compounds/therapeutics validated per week1000+ parallel autonomous experimentsContinuous
R&D EfficiencyCost and timeline reduction vs traditional methods40%+ cost reduction, 10x faster validationPer enterprise partnership
Experimental ReproducibilityDigital capture of complete scientific method execution97.8% reproducibility across AI Science FactoriesEvery experiment
Domain CoverageLife/chemical/materials science capabilityFull-stack autonomous coverage across three domainsExpanding continuously
Hardware IntegrationRobotic lab orchestration and scalabilityAI Science Factories with state-of-the-art automationInfrastructure scaling
Enterprise ReadinessSecure, scalable IP-protected discovery workflowsCommercial partnerships with fidelity data handlingPer deployment

Expert Reviews

📝

No reviews yet

Be the first to review Lila Sciences!

Write a Review

Similar Products

Thinking Machines Lab
thinkingmachines.ai
Axiom Math
axiommath.ai
Reflection AI
reflection.ai